Washed Microbiota Transplantation for Diabetic Gastroparesis

Status Recruiting

Clinical Trial Summary

This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.

Clinical Trial Description

At least 44 subjects who meet all the inclusion criteria but do not meet any exclusion criteria will be enrolled in this study. Data of demographic characteristics, Gastroparesis Cardinal Symptom Index (GCSI), Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM), Gastroparesis Core Symptom Daily Diary (GCS-DD), Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QoL), and clinical outcomes will be collected. After treatment, they will enter the follow-up period for efficacy and safety evaluation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06340217
Study type	Interventional
Source	The Second Hospital of Nanjing Medical University
Contact	Faming Zhang, PhD
Phone	086-025-58509883
Email	fzhang@njmu.edu.cn
Status	Recruiting
Phase	N/A
Start date	April 1, 2024
Completion date	July 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01557296` - Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis	Phase 2
Withdrawn	`NCT03376399` - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Completed	`NCT02289846` - Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)	Phase 2
Not yet recruiting	`NCT02264587` - Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis	Phase 4
Completed	`NCT03544229` - A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis	Phase 2
Recruiting	`NCT04706832` - Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study	N/A
Not yet recruiting	`NCT05584462` - Gastroparesis in type2 Diabetic Patient
Enrolling by invitation	`NCT05812339` - Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Completed	`NCT02732821` - G-POEM for Treatment of Refractory Gastroparesis
Completed	`NCT01030341` - Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis	N/A
Recruiting	`NCT05832151` - A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Phase 2
Completed	`NCT02025725` - Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis	Phase 3
Completed	`NCT01916460` - Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients	N/A
Completed	`NCT01469286` - Transcutaneous Electroacupuncture for Gastroparesis	Phase 1
Terminated	`NCT00874133` - The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis	N/A
Completed	`NCT01126034` - Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention	N/A
Recruiting	`NCT05273788` - Thoracic Neuromodulation for Diabetic Gastroparesis	N/A
Suspended	`NCT00470795` - Acupuncture for Diabetic Gastroparesis	Phase 3
Completed	`NCT00139893` - A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis	N/A
Recruiting	`NCT04254549` - Rifaximin in Patients With Diabetic Gastroparesis	Phase 2